Cargando…
FTZ Ameliorates Diabetic Cardiomyopathy by Inhibiting Inflammation and Cardiac Fibrosis in the Streptozotocin-Induced Model
BACKGROUND: The pathogenesis and clinical features of diabetic cardiomyopathy (DCM) have been well studied in the past decade; however, effective approaches to prevent and treat this disease are limited. Fufang Zhenzhu Tiaozhi (FTZ) formula, a traditional Chinese prescription, is habitually used to...
Autores principales: | Wang, Lexun, Wu, Huijuan, Deng, Yanyue, Zhang, Shengxi, Wei, Quxing, Yang, Qianqian, Piao, Shenghua, Bei, Weijian, Rong, Xianglu, Guo, Jiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492284/ https://www.ncbi.nlm.nih.gov/pubmed/34621323 http://dx.doi.org/10.1155/2021/5582567 |
Ejemplares similares
-
CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding
por: Wang, Lexun, et al.
Publicado: (2022) -
Long-Term Effect of Zhenzhu Tiaozhi Capsule (FTZ) on Hyperlipidemia: 2-Year Results from a Retrospective Study Using Electronic Medical Records
por: Huang, Xiaoqiang, et al.
Publicado: (2021) -
The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Wang, Lexun, et al.
Publicado: (2021) -
The markers to delineate different phenotypes of macrophages related to metabolic disorders
por: Wei, Quxing, et al.
Publicado: (2023) -
Chinese Medicine FTZ Recipe Protects against High-Glucose-Induced Beta Cell Injury through Alleviating Oxidative Stress
por: Bei, Weijian, et al.
Publicado: (2019)